Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|April 27, 2018
Current use of monoclonal antibodies in the treatment of multiple myelomaCindy Varga, Michelle Maglio, Irene M Ghobrial, et al.
Blood Reviews|June 7, 2019
Use of novel therapies in the treatment of light chain amyloidosisCindy Varga, Stephanie E Titus, Denis Toskic, et al.
Clinical Advances in Hematology & Oncology : H&O|January 6, 2021
Current antibody-based therapies for the treatment of multiple myelomaCindy Varga, Johannes M Waldschmidt, Sara Gandolfi, et al.
Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.
Blood Reviews|May 17, 2025
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibodyAnam Ashfaque, Yara Shatnawi, Shahzad Raza, et al.
British Journal of Haematology|May 12, 2018
Investigational agents in immunotherapy: a new horizon for the treatment of multiple myelomaCindy Varga, Jacob P Laubach, Kenneth C Anderson, et al.
Jornal Brasileiro De Nefrologia|December 22, 2016
Acute myeloid leukemia after kidney transplantation: a case report and literature reviewFrancesca Cardarelli, Vanesa Bijol, Anil Chandraker, et al.
Blood Reviews|September 11, 2019
Treatment of relapsed multiple myeloma: Evidence-based recommendationsCeren Durer, Seren Durer, Sarah Lee, et al.
Transfusion|October 17, 2012
The effectiveness and safety of fixed low-dose prothrombin complex concentrates in patients requiring urgent reversal of warfarinCindy Varga, Sultan Al-Touri, Stella Papadoukakis, et al.
Annals of Hematology|November 8, 2021
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/amplification in the era of modern therapyXiao Hu, Cherng-Horng Wu, Janet M Cowan, et al.
Pageof 6